论文部分内容阅读
因被疑致多名婴儿死亡,深圳康泰生物制品股份有限公司生产的重组乙型肝炎疫苗被暂停使用。对于产品缺口,国家食药监总局曾表示由天坛生物等5家疫苗生产企业填补。但无独有偶,昨日,四川、湖北两婴儿注射天坛生物产乙肝疫苗后死亡,这让国内疫苗行业安全性遭到考问。有媒体曝出,四川眉山现一例婴儿打乙肝疫苗
Due to the suspected number of infants who died, Shenzhen Kangtai Biological Products Co., Ltd. production of recombinant hepatitis B vaccine was suspended. For the product gap, the State Food and Drug Administration has said that by the Tiantan Biological and other five vaccine manufacturers to fill. However, coincidentally, yesterday, Sichuan and Hubei, two infants died after the injection of the Tiantan Biological Hepatitis B vaccine, which made the safety of the domestic vaccine industry was questioned. There are media reports, a case of Meishan in Sichuan Province to play a hepatitis B vaccine